Pfizer at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Pfizer brings 11 presentations to ASH 2026 in New Orleans, and exhibits at Booth 2039. Pfizer presents sponsored sessions on marstacimab for hemophilia and a BCMA-directed myeloma therapy, and hosts trial showcases for osivelotor in sickle cell disease. Its research covers marstacimab dosing in children.
| Organization | ASH 2026 Attendance |
|---|---|
Pfizer New York, NY | |
Global pharmaceutical company whose hematology portfolio spans myeloma, leukemia and hemophilia medicines. | Booth Exhibiting at Booth 2039 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Talk Sat Dec 12 8:00am–9:00am Talk Sat Dec 12 11:30am–12:30pm Oral Sat Dec 12 4:00pm–5:30pm Poster Sat Dec 12 5:30pm–7:30pm Talk Sun Dec 13 8:00am–9:00am Talk Sun Dec 13 4:15pm–4:30pm Talk Sun Dec 13 4:30pm–6:00pm Talk Mon Dec 14 8:00am–9:00am Talk Mon Dec 14 10:00am–10:15am Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Pfizer
Tell us what you sell and we’ll find the people at Pfizer most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction